Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 1
2008 3
2009 1
2011 3
2012 5
2013 2
2014 5
2015 14
2016 15
2017 15
2018 11
2019 19
2020 10
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 32988910

93 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Significance of Glioma-associated Oncogene 1 Expression in Patients With Locally Advanced Gastric Cancer Administered Adjuvant Chemotherapy With S-1 After Curative Surgery.
Hashimoto I, Oue N, Kimura Y, Hiroshima Y, Hara K, Maezawa Y, Kano K, Fujikawa H, Aoyama T, Numata M, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Shiozawa M, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T. Hashimoto I, et al. Anticancer Res. 2020 Oct;40(10):5815-5821. doi: 10.21873/anticanres.14599. Anticancer Res. 2020. PMID: 32988910
High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.
Maezawa Y, Sakamaki K, Oue N, Kimura Y, Hashimoto I, Hara K, Kano K, Aoyama T, Hiroshima Y, Yamada T, Yamamoto N, Ogata T, Ito H, Cho H, Shiozawa M, Yoshikawa T, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T. Maezawa Y, et al. J Cancer Res Clin Oncol. 2020 Jan;146(1):75-86. doi: 10.1007/s00432-019-03087-8. Epub 2019 Nov 21. J Cancer Res Clin Oncol. 2020. PMID: 31754833 Free PMC article.
Clinical Significance of PLA2G2A Expression in Gastric Cancer Patients who Receive Gastrectomy and Adjuvant S-1.
Hatori S, Sakamaki K, Yokohori T, Kimura Y, Hiroshima Y, Hashimoto I, Komori K, Watanabe H, Kano K, Fujikawa H, Aoyama T, Numata M, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Shizawa M, Yukawa N, Morinaga S, Rino Y, Masuda M, Saeki H, Miyagi Y, Oshima T. Hatori S, et al. Anticancer Res. 2021 Jul;41(7):3583-3588. doi: 10.21873/anticanres.15146. Anticancer Res. 2021. PMID: 34230154
Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1.
Numata K, Oshima T, Sakamaki K, Yoshihara K, Aoyama T, Hayashi T, Yamada T, Sato T, Cho H, Shiozawa M, Yoshikawa T, Rino Y, Kunisaki C, Akaike M, Imada T, Masuda M. Numata K, et al. J Cancer Res Clin Oncol. 2016 Feb;142(2):415-22. doi: 10.1007/s00432-015-2039-6. Epub 2015 Sep 3. J Cancer Res Clin Oncol. 2016. PMID: 26337161
Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer.
Ichikawa W, Terashima M, Ochiai A, Kitada K, Kurahashi I, Sakuramoto S, Katai H, Sano T, Imamura H, Sasako M. Ichikawa W, et al. Gastric Cancer. 2017 Mar;20(2):263-273. doi: 10.1007/s10120-016-0600-x. Epub 2016 Feb 16. Gastric Cancer. 2017. PMID: 26884344 Free PMC article.
Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A, Yoshida K, Kobayashi M, Yoshino S, Takahashi M, Takiguchi N, Tanabe K, Takahashi N, Imamura H, Tatsumoto N, Hara A, Nishikawa K, Fukushima R, Nozaki I, Kojima H, Miyashita Y, Oba K, Buyse M, Morita S, Sakamoto J. Tsuburaya A, et al. Lancet Oncol. 2014 Jul;15(8):886-93. doi: 10.1016/S1470-2045(14)70025-7. Epub 2014 Jun 18. Lancet Oncol. 2014. PMID: 24954805 Clinical Trial.
93 results